Heart transplantation and anti-HLA antibodY: myocardial dysfunction and prognosis - HeartLAy study.

Abstract

The presence of anti-human leucocyte antigen (HLA) antibodies has been implicated in a higher incidence of complications as well as mortality rate in heart transplantation. The aim of the study was to identify through non-invasive parameters early signs of myocardial dysfunction in the presence of anti-HLA antibodies but without evidence of antibody-mediated rejection (AMR) and its possible prognostic impact. A total of 113 heart-transplanted patients without acute cellular rejection (ACR) and AMR or cardiac allograft vasculopathy (CAV) were prospectively enrolled and divided into two groups ['HLA+' (50 patients) and 'HLA-' (63 patients)], based on the presence of anti-HLA antibodies. Each patient was followed for 2years after the enrolment, recording episodes of AMR, ACR, CAV, and mortality. Clinical characteristics were similar between the two groups. Among laboratory data, N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin values were significantly higher in the presence of anti-HLA antibodies (P<0.001 and P=0.003, respectively). The echocardiographic parameters that showed a statistically significant difference between the two groups were deceleration time of E wave (DecT E, P<0.001), left ventricular global longitudinal strain (P<0.001), tricuspid annular plane systolic excursion (P=0.011), tricuspid S' wave (P=0.002), and free wall right ventricular longitudinal strain (fwRVLS, P=0.027), whereas left atrial strain did not differ significantly (P=0.408). Univariate analysis showed that anti-HLA antibodies were associated with the development of CAV at both 1 and 2year follow-up [odds ratio (OR) 11.90, 95% confidence interval (CI) 1.43-90.79, P=0.022 and OR 3.37, 95% CI 1.78-9.67, P=0.024, respectively]. Bivariate analysis demonstrated that both fwRVLS and DecT E were predictors of CAV development independently from HLA status. The presence of circulating anti-HLA antibodies is correlated with a mild cardiac dysfunction, even in the absence of AMR, and CAV development. Interestingly, reduced values of DecT E and fwRVLS were predictors of future development of CAV, independently from anti-HLA antibody.